Related references
Note: Only part of the references are listed.Targeted gene panel sequencing in early infantile onset developmental and epileptic encephalopathy
Ji-Hoon Na et al.
BRAIN & DEVELOPMENT (2020)
Advances in genetic testing and optimization of clinical management in children and adults with epilepsy
Marcello Scala et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2020)
Definitions and classification of malformations of cortical development: practical guidelines
Mariasavina Severino et al.
BRAIN (2020)
Fenfluramine for the Treatment of Dravet Syndrome and Lennox-Gastaut Syndrome
Ganna Balagura et al.
CNS DRUGS (2020)
Genotype-phenotype correlations in patients with de novo KCNQ2 pathogenic variants
Federica Malerba et al.
NEUROLOGY-GENETICS (2020)
Lacosamide in children with drug-resistant epilepsy
Andrea D. Ruegger et al.
JOURNAL OF PAEDIATRICS AND CHILD HEALTH (2019)
Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test
Anath C. Lionel et al.
GENETICS IN MEDICINE (2018)
De novo mutations of STXBP1 in Chinese children with early onset epileptic encephalopathy
T. Li et al.
GENES BRAIN AND BEHAVIOR (2018)
Infantile Epileptic Encephalopathy With Multiple Genetic Mutations: How Important are Variants of Undetermined Significance?
Momen Almomen et al.
SEMINARS IN PEDIATRIC NEUROLOGY (2018)
Neurodevelopmental Genetic Diseases Associated With Microdeletions and Microduplications of Chromosome 17p13.3
Sara M. Blazejewski et al.
FRONTIERS IN GENETICS (2018)
Infantile spasms and encephalopathy without preceding neonatal seizures caused by KCNQ2 R198Q, a gain-of-function variant
John J. Millichap et al.
EPILEPSIA (2017)
ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology
Ingrid E. Scheffer et al.
EPILEPSIA (2017)
Models for discovery of targeted therapy in genetic epileptic encephalopathies
Snezana Maljevic et al.
JOURNAL OF NEUROCHEMISTRY (2017)
Clinical and genetic factors predicting Dravet syndrome in infants with SCN1A mutations
Valentina Cetica et al.
NEUROLOGY (2017)
Treatment of Epileptic Encephalopathies
Simona Balestrini et al.
CURRENT PHARMACEUTICAL DESIGN (2017)
Hypotonia and intellectual disability without dysmorphic features in a patient with PIGN-related disease
Isabelle Thiffault et al.
BMC MEDICAL GENETICS (2017)
Gene mutation analysis of 175 Chinese patients with early-onset epileptic encephalopathy
Q. Zhang et al.
CLINICAL GENETICS (2017)
Genotype-Phenotype Correlation of Congenital Anomalies in Multiple Congenital Anomalies Hypotonia Seizures Syndrome (MCAHS1)/PIGN-Related Epilepsy
Leah Fleming et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2016)
The genetic landscape of the epileptic encephalopathies of infancy and childhood
Amy McTague et al.
LANCET NEUROLOGY (2016)
STXBP1 encephalopathy A neurodevelopmental disorder including epilepsy
Hannah Stamberger et al.
NEUROLOGY (2016)
Epileptic Encephalopathy in Infants and Children
Carl E. Stafstrom et al.
EPILEPSY CURRENTS (2016)
The Phenotype of Multiple Congenital Anomalies-Hypotonia-Seizures Syndrome 1: Report and Review
Natario L. Couser et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2015)
Epileptic patients with de novo STXBP1 mutations: Key clinical features based on 24 cases
Chloe Di Meglio et al.
EPILEPSIA (2015)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
PIGN mutations cause congenital anomalies, developmental delay, hypotonia, epilepsy, and progressive cerebellar atrophy
Chihiro Ohba et al.
NEUROGENETICS (2014)
SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information
Marco Biasini et al.
NUCLEIC ACIDS RESEARCH (2014)
Folinic Acid Responsive Epilepsy in Ohtahara Syndrome Caused by STXBP1 Mutation
Winnie W. Y. Tso et al.
PEDIATRIC NEUROLOGY (2014)
Clinical spectrum of SCN2A mutations
Xiuyu Shi et al.
BRAIN & DEVELOPMENT (2012)
Lacosamide in Lennox-Gastaut Syndrome: Case Report
Rene Andrade-Machado et al.
CLINICAL NEUROPHARMACOLOGY (2012)
Neurology of inherited glycosylation disorders
Hudson H. Freeze et al.
LANCET NEUROLOGY (2012)
Xp22.3 genomic deletions involving the CDKL5 gene in girls with early onset epileptic encephalopathy
Davide Mei et al.
EPILEPSIA (2010)
Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005-2009
Anne T. Berg et al.
EPILEPSIA (2010)
Lacosamide: pharmacology, mechanisms of action and pooled efficacy and safety data in partial-onset seizures
Ahmad Beydoun et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2009)
The three stages of epilepsy in patients with CDKL5 mutations
Nadia Bahi-Buisson et al.
EPILEPSIA (2008)
Clinical and electroencephalographic features in patients with CDKL5 mutations: Two new Italian cases and review of the literature
Maria Pintaudi et al.
EPILEPSY & BEHAVIOR (2008)
CDKL5 mutations cause infantile spasms, early onset seizures, and severe mental retardation in female patients
H. L. Archer et al.
JOURNAL OF MEDICAL GENETICS (2006)
Clinical and molecular basis of classical lissencephaly: Mutations in the LIS1 gene (PAFAH1B1)
C Cardoso et al.
HUMAN MUTATION (2002)
De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy
L Claes et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Share Paper
